Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Drug Metab Dispos ; 38(1): 187-99, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19797609

RESUMO

CYP2D6 and CYP3A4, two members of the cytochrome P450 superfamily of monooxygenases, mediate the biotransformation of a variety of xenobiotics. The two enzymes differ in substrate specificity and size and characteristics of the active site cavity. The aim of this study was to determine whether the catalytic properties of these isoforms, reflected by the differences observed from crystal structures and homology models, could be confirmed with experimental data. Detailed metabolite identification, reversible inhibition, and time-dependent inhibition were examined for levorphanol and levallorphan with CYP2D6 and CYP3A4. The studies were designed to provide a comparison of the orientations of substrates, the catalytic sites of the two enzymes, and the subsequent outcomes on metabolism and inhibition. The metabolite identification revealed that CYP3A4 catalyzed the formation of a variety of metabolites as a result of presenting different parts of the substrates to the heme. CYP2D6 was a poorer catalyst that led to a more limited number of metabolites that were interpreted in terms to two orientations of the substrates. The inhibition studies showed evidence for strong reversible inhibition of CYP2D6 but not for CYP3A4. Levallorphan acted as a time-dependent inhibitor on CYP3A4, indicating a productive binding mode with this enzyme not observed with CYP2D6 that presumably resulted from close interactions of the N-allyl moiety oriented toward the heme. All the results are in agreement with the large and flexible active site of CYP3A4 and the more restricted active site of CYP2D6.


Assuntos
Biocatálise , Citocromo P-450 CYP2D6/metabolismo , Citocromo P-450 CYP3A/metabolismo , Levalorfano/metabolismo , Levorfanol/metabolismo , Domínio Catalítico , Cromatografia Líquida de Alta Pressão , Citocromo P-450 CYP2D6/química , Inibidores do Citocromo P-450 CYP2D6 , Citocromo P-450 CYP3A/química , Inibidores Enzimáticos/química , Inibidores Enzimáticos/metabolismo , Glutationa/metabolismo , Humanos , Interações Hidrofóbicas e Hidrofílicas , Cinética , Levalorfano/análogos & derivados , Levalorfano/análise , Levalorfano/química , Levorfanol/análogos & derivados , Levorfanol/análise , Levorfanol/química , Modelos Químicos , Modelos Moleculares , Estrutura Molecular , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Espectrometria de Massas por Ionização por Electrospray , Eletricidade Estática , Espectrometria de Massas em Tandem , Termodinâmica
2.
J Pharm Biomed Anal ; 11(4-5): 335-8, 1993.
Artigo em Inglês | MEDLINE | ID: mdl-8357869

RESUMO

A sensitive and specific quantitative method for the determination of zipeprol, a newly abused antitussive, in human fluids is described. Zipeprol and an internal standard, levallorphan, are isolated by a basic extraction and back-extraction process. The final extract is derivatizated with BSTFA + 1% TMCS and separated on a 12-m HP-1 capillary column. Drugs are detected by selected ion monitoring at m/z 335 and m/z 355 for zipeprol and the internal standard, respectively. The minimum detectable quantities are 0.6 and 0.4 ng ml-1, for zipeprol in plasma and urine, respectively. Relative standard deviations for within-run data are less than 6%.


Assuntos
Antitussígenos/análise , Piperazinas/análise , Adulto , Antitussígenos/sangue , Antitussígenos/intoxicação , Cromatografia Gasosa-Espectrometria de Massas , Conteúdo Gastrointestinal/química , Humanos , Indicadores e Reagentes , Levalorfano/análise , Masculino , Piperazinas/sangue , Piperazinas/intoxicação , Solventes , Tentativa de Suicídio
3.
Biol Mass Spectrom ; 22(4): 226-34, 1993 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-8481410

RESUMO

To gather more information on stereochemical factors in the hepatic disposition of organic cations, mass spectrometry coupled to liquid chromatography was used to determine the identity of the metabolites excreted in bile after isolated rat liver perfusions with the quaternary ammonium derivatives of the enantiomeric drugs dextrorphan and levorphanol. Ionspray mass spectrometry was chosen for its soft ionization and absence of thermal degradation of labile compounds. The drugs were labelled with a stable (2H) isotope and mixed with unlabelled drugs to create an artificial isotope pattern in the mass spectrum and facilitate the recognition of unknown metabolites. In mass spectra that were recorded under normal conditions, fragmentation was absent and metabolites of N-methyl dextrorphan and N-methyl levorphanol were visible as parent-ion 'doublets'. Collision-induced fragmentation studies were performed to support the identification of the metabolites. For N-methyl dextrorphan the glucuronide, the glutathione conjugate and the glucuronide of the N-demethylated metabolite were found in bile. For N-methyl levorphanol the glucuronide, the glutathione conjugate, the sulphate conjugate and the glucuronide of a hydroxylated N-methyl levorphanol were excreted in bile. Thus a remarkable stereoselectivity occurs in the metabolism of these quaternary ammonium compounds in the rat liver.


Assuntos
Dextrorfano/análise , Levalorfano/análogos & derivados , Fígado/metabolismo , Animais , Bile/metabolismo , Cromatografia Líquida , Dextrorfano/análogos & derivados , Técnicas In Vitro , Levalorfano/análise , Levalorfano/metabolismo , Fígado/química , Espectroscopia de Ressonância Magnética , Masculino , Espectrometria de Massas , Conformação Molecular , Perfusão , Ratos , Ratos Wistar , Estereoisomerismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...